Articles
Start “Early” in Healthy for timely results for your dosage form
Early phase bioequivalence studies are/can be conducted on all USFDA Orange book approved list of dosage forms based on submission requirements by pharmaceutical companies...
Articles
Managing Risks With Potent Pharmaceutical Products
As a noticeable shift occurs in the pharmaceutical industry from blockbuster drugs to smaller patient populations, there is an increased focus on targeted therapies...
Articles
Integrating biological safety cabinets into the cGMP environment to support aseptic processing
Pharmaceutical manufacturers have a duty to deliver consistently safe and effective medicines, and a fundamental part of this is ensuring products do not contain...
Press Releases
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a multi-project collaboration with Otsuka Pharmaceutical Co.,...
Clinical Trials
Epizyme Announces U.S. FDA Approval of TAZVERIK for the Treatment of Patients with Epithelioid Sarcoma
Epizyme, Inc., a biopharmaceutical company developing novel epigenetic therapies, announced that the U.S. FDA has granted accelerated approval of TAZVERIK for the treatment of...
Drug Research
Predictive Oncology Acquire Quantitative Medicine and an AI Engine that Facilitates Accelerated Drug Discovery and Development
Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, announces it has signed a letter...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read